The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo☆
暂无分享，去创建一个
T. Mohr | W. Berger | B. Keppler | W. Körner | G. Koellensperger | P. Heffeter | K. Kryeziu | Diana Groza | U. Jungwirth | D. Groza | Bihter Atil